Valuation : Incyte Corporation

Market Cap 2.6TCr 2.23TCr 2.09TCr 1.91TCr 3.6TCr 2,48000Cr 3.61TCr 25TCr 9.66TCr 1,25000Cr 9.75TCr 9.54TCr 4,13700Cr P/E 2026 *
57.2x
P/E 2027 * 17.7x
Enterprise Value 2.17TCr 1.87TCr 1.75TCr 1.6TCr 3.01TCr 2,07600Cr 3.02TCr 21TCr 8.09TCr 1,04600Cr 8.16TCr 7.99TCr 3,46300Cr EV / Sales 2026 *
3.66x
EV / Sales 2027 * 3.19x
Free-Float
98.16%
Yield 2026 *
-
Yield 2027 * -
1 day-0.30%
1 week+0.41%
Current month+6.88%
1 month+7.46%
3 months+31.23%
6 months+26.14%
Current year+29.33%
1 week 125.6
Extreme 125.6
130.8
1 month 115.77
Extreme 115.77
132.6
Current year 89.25
Extreme 89.25
132.6
1 year 81.09
Extreme 81.09
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
19/08/26 Sell

Chairperson

-10,801 0.0053%
12/08/26 Sell

Chairperson

-10,803 0.0053%
05/08/26 Fiscal year

EVP & Chief Scientific Officer

6,621 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
-0.30%+0.41%+50.57%+97.04% 2.6TCr
-0.87%-2.29%+37.61%-2.79% 8.14TCr
-4.60%+7.09%+468.80%+25.42% 5.97TCr
+0.84%+4.44%-19.19%-35.11% 5.92TCr
+0.76%+3.53%+0.08%+36.18% 5.33TCr
+0.41%+1.88%+11.09%+171.67% 4.91TCr
+0.19%+3.34%+62.44%-16.43% 3.27TCr
-2.00%+9.52%+12.38%+218.34% 2.44TCr
+0.78%+0.47%+61.53%+123.40% 1.69TCr
-4.68%+2.52%-9.33%+752.25% 1.56TCr
Average -0.95%+0.21%+67.60%+137.00% 4.18TCr
Weighted average by Cap. -0.83%-0.95%+83.75%+73.47%

Financials

2026 *2027 *
Net sales 594.19Cr 510.06Cr 477.52Cr 437.26Cr 823.71Cr 57TCr 826.05Cr 5.65TCr 2.21TCr 29TCr 2.23TCr 2.18TCr 95TCr 626.5Cr 537.79Cr 503.49Cr 461.04Cr 868.5Cr 60TCr 870.96Cr 5.96TCr 2.33TCr 30TCr 2.35TCr 2.3TCr 1LCr
Net income 47Cr 40Cr 37Cr 34Cr 65Cr 4.45TCr 65Cr 443.3Cr 173.29Cr 2.24TCr 174.9Cr 171.12Cr 7.42TCr 149.59Cr 128.4Cr 120.21Cr 110.08Cr 207.37Cr 14TCr 207.95Cr 1.42TCr 556.47Cr 7.2TCr 561.62Cr 549.49Cr 24TCr
Net Debt -422.97Cr -363.08Cr -339.92Cr -311.26Cr -586.35Cr -40TCr -588.01Cr -4.03TCr -1.57TCr -20TCr -1.59TCr -1.55TCr -67TCr -599.09Cr -514.26Cr -481.46Cr -440.86Cr -830.5Cr -57TCr -832.85Cr -5.7TCr -2.23TCr -29TCr -2.25TCr -2.2TCr -95TCr
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
28/26/28 $127.74 -0.30% 7,00,415
26/26/26 $128.12 -1.23% 8,00,283
25/26/25 $129.72 +1.36% 11,62,238
24/26/24 $127.98 +0.13% 7,99,608
21/26/21 $127.81 +0.46% 13,67,411
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
128.12USD
Average target price
127.12USD
Spread / Average Target
-0.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock